-
- 1800 2010
- EN
Gentis news
Array
(
[0] => stdClass Object
(
[id] => 1393
[id_crawler] =>
[category_product] => NULL
[thumbnail] => dsc09793.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 1
[displayed_time] => 2025-12-18
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-12-18 09:02:36
[updated_time] => 2025-12-18 11:21:18
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => Preimplantation-genetic-testing-A-key-to-improving-IVF-success-and-protecting-future-generations
[title] => Preimplantation genetic testing: A key to improving IVF success and protecting future generations
[description] => In recent years, in vitro fertilization (IVF) has become a vital solution helping tens of thousands of Vietnamese couples realize their dream of parenthood.
[content] => Each year, approximately 50,000 IVF cycles are performed in Vietnam, making the country one of the fastest-growing IVF markets in the region. However, alongside this growth come increasingly evident challenges: how to improve success rates, reduce the number of embryo transfers, optimize treatment costs, and—most importantly—ensure the long-term birth of healthy babies. Advanced genetic solutions are playing a pivotal role, laying the foundation for modern, precise, and sustainable reproductive medicine. IVF success rates vary by center and patient age; they are commonly reported at around 40–50% in younger patient groups and decline significantly with increasing maternal age, as well as other influencing factors such as oocyte and sperm quality, endometrial conditions, and embryo quality.
Preimplantation Genetic Testing (PGT) has become one of the most important tools for enhancing the quality of IVF treatment. PGT enables genetic evaluation of embryos prior to uterine transfer, thereby supporting the selection of embryos with high implantation potential and reducing the risk of genetic abnormalities. At EUROFINS GENTIS, a comprehensive PGT testing system—including PGT-A, PGT-SR, PGT-M, PGT-NEXT, and PGT-UPGRADE—is implemented in an integrated manner, providing physicians and patients with stronger scientific evidence to select optimal embryos, minimize risks, and improve IVF success rates.
PGT-M – Protecting future generations from monogenic genetic disorders
In addition to chromosomal abnormalities, monogenic genetic disorders continue to silently affect the health and happiness of many Vietnamese families. These conditions are often detected only after birth, leading to long-term treatment burdens and significantly impacting the quality of life of families and society as a whole.
Prof. Dr. Nguyen Dinh Tao (Chairman of Hanoi Assisted Reproduction) has highlighted PGT-M at EUROFINS GENTIS as a pioneering solution in early genetic disease prevention strategies. He noted that PGT-M enables accurate detection of known disease-causing mutations identified in parents or within families, allowing for the screening and selection of unaffected embryos prior to transfer. A key strength of PGT-M at EUROFINS GENTIS lies in its closed-loop and highly individualized process, which includes in-depth genetic counseling, identification of disease-related mutations, tailored test strategy design, and embryo genetic analysis using next-generation sequencing (NGS) technology. This solution can be applied to a wide range of genetic disorders, including rare diseases, opening opportunities for healthy childbirth among high-risk couples. Beyond its clinical value in establishing pregnancies unaffected by specific inherited traits—such as known pathogenic variants carried by one or both parents—PGT-M also helps reduce long-term treatment burdens, lower societal healthcare costs, and improve overall population health.
PGT-AI – AI breakthroughs in reproductive genetics
Alongside rapid advances in digital technology, artificial intelligence (AI) and bioinformatics are driving profound changes in reproductive medicine. Beyond genetic data analysis alone, AI enables the integration of multiple data sources—such as embryo imaging, molecular biology data, and clinical factors—thereby generating more accurate predictive models of embryo implantation potential and developmental outcomes.
Speaking at the HASAM 2025 conference, Dr. Pham Dinh Minh (R&D Director, EUROFINS GENTIS) introduced a new test researched and piloted by EUROFINS GENTIS: PGT-AI (icOne)—an advanced AI algorithm certified by the FDA, enabling in-depth analysis of embryo genetic data using modern machine learning platforms. This technology overcomes limitations of traditional PGT methods and supports more precise and personalized clinical decision-making for each patient.
Dr. Minh further noted that EUROFINS GENTIS is currently the exclusive partner implementing PGT-AI (icOne) in Vietnam, marking a significant milestone in bringing world-leading medical technologies closer to domestic patients. The combination of AI, bioinformatics, and the extensive expertise of specialist teams has enhanced IVF effectiveness while optimizing treatment costs and patient experience.
International quality management systems – The foundation for PGT accuracy
In reproductive genetics, particularly PGT testing, quality management systems play a decisive role in ensuring accuracy and reliability of results, directly influencing embryo selection, IVF treatment outcomes, and the future of each family. According to Dr. Nguyen Quang Vinh (Laboratory Director, EUROFINS GENTIS): “The comprehensive quality management system at EUROFINS GENTIS is built and operated in accordance with strict international standards such as ISO 15189, CAP, and CLSI. This ensures standardization across the entire PGT testing workflow—from receiving embryo biopsy samples, DNA processing, NGS and bioinformatics data analysis, to final reporting. Rigorous control at every step not only minimizes technical errors and ensures consistency and reproducibility of results, but also enhances safety, data security, and traceability, thereby supporting more accurate clinical decision-making.”
Together with internationally accredited laboratories, strict DNA contamination control environments, and highly experienced experts, EUROFINS GENTIS maintains high reliability in PGT testing while establishing a solid foundation for implementing advanced technologies such as PGT-AI—contributing to improved IVF outcomes and strengthening the trust of IVF centers and patients nationwide.
Accompanying the journey to parenthood
Guided by science, technology, and quality, EUROFINS GENTIS not only provides advanced genetic testing services but also serves as a trusted partner to IVF centers and Vietnamese families on their journey toward parenthood. Through the application of modern genetic technologies, EUROFINS GENTIS is steadily contributing to higher IVF success rates, early prevention of genetic diseases, and the sustainable development of reproductive medicine in Vietnam.
[content_more] =>
[meta_title] => Preimplantation genetic testing: A key to improving IVF success and protecting future generations
[meta_description] => Preimplantation Genetic Testing (PGT) has become one of the most important tools for enhancing the quality of IVF treatment. PGT enables genetic evaluation of embryos prior to uterine transfer, thereby supporting the selection of embryos with high implant
[meta_keyword] => GENTIS,PGT
[thumbnail_alt] =>
[post_id] => 1393
[category_id] => 14
)
[1] => stdClass Object
(
[id] => 1392
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 596067328_1263300952501760_1825096505615856739_n.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2025-11-12
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-12-12 15:41:15
[updated_time] => 2025-12-22 11:35:26
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => Eurofins-GENTIS-partners-with-Hanoi-hospital-of-andrology-and-infertility-to-host-the-december-prenatal-class
[title] => Eurofins GENTIS partners with Hanoi hospital of andrology and infertility to host the december prenatal class
[description] => The journey of pregnancy is a sacred experience, one filled with unique emotions for every mother. It is the overwhelming joy of discovering the presence of a beloved baby, the day-by-day anticipation of feeling those first tiny movements, and at the same time, countless questions and concerns about health, nutrition, labor, and newborn care.
[content] => Understanding these concerns, Eurofins GENTIS is proud to partner with the Hanoi Hospital of Andrology and Infertility (AF HANOI) to organize the Prenatal Class – The Journey to Happy Motherhood, offering expectant mothers a warm, supportive space to gain knowledge and meaningful connection.
A special space for expectant mothers – where the journey to motherhood becomes sweeter
The prenatal class is not simply a session on pregnancy knowledge; it is a place where mothers-to-be and fathers-to-be can find reassurance, support, and love. It is an opportunity for future parents to prepare a solid foundation together before welcoming their little angel.
AF HANOI and Eurofins GENTIS aim to create a gentle, friendly learning environment where every mother feels comfortable sharing her concerns and receiving guidance from leading experts in obstetrics and gynecology.
Expert participation – the highlight of the Prenatal Class
At this session, expectant mothers will have the opportunity to listen to practical and valuable professional insights from two experienced doctors:
-
Dr. Nguyen Thi Hong Nhung, MD – Specialist in Obstetrics & Gynecology
-
Dr. Dam Dinh Tam, MD – Specialist in Obstetrics & Gynecology
With many years of experience accompanying pregnant women, these experts will deliver a friendly, practical, and informative session, helping young parents better understand fetal development and the changes in the mother’s body throughout pregnancy.
Prenatal Class – The journey to happy motherhood includes a wide range of topics, such as:
Essential knowledge on prenatal care
Mothers will be guided on appropriate nutrition, gentle exercises, proper health monitoring, warning signs to watch for, and ways to care for mental well-being to stay positive throughout the nine months and ten days of pregnancy.
Understanding labor and achieving a safe delivery
From signs of labor and bodily changes, to proper breathing and pushing techniques, and preparing a hospital bag—everything will be explained in detail by doctors to help mothers feel more confident during this important moment.
Scientific newborn care from the very first days of life
Caring for a newborn is always a major challenge, especially for first-time mothers. In the class, mothers will learn essential basics such as proper breastfeeding, bathing a baby, and handling common newborn issues.
Comprehensive Q&A from A to Z
Beyond passive learning, expectant mothers can ask doctors questions directly. Any concern—no matter how small—will be answered thoughtfully and thoroughly by the experts.
AF HANOI and Eurofins GENTIS hope to spread a sense of calm and reassurance to all participating mothers. Therefore, each mother will receive a small gift as a wish for a healthy pregnancy and a gentle, fulfilling motherhood journey.
Event Information
Time: 09:30 – 11:00, Saturday, December 27, 2025
Venue: 5th Floor Auditorium – Hanoi Hospital of Andrology and Infertility
Register now: forms.gle/kn6tj49GxxyqjbZy5
Or scan the QR code in the image to secure your seat early!
Seats are limited to ensure the quality of the class, so expectant mothers are encouraged to register early to avoid missing out.
Eurofins GENTIS – Accompanying mothers through every loving moment
Eurofins GENTIS deeply values every mother’s journey and believes that when mothers are well prepared with knowledge and emotional readiness, pregnancy becomes the most beautiful and peaceful time of life. By partnering with AF HANOI in this prenatal class, GENTIS hopes to bring mothers:
-
Peace of mind in every decision
-
Proactive confidence throughout pregnancy
-
Love that reaches babies from the very first days of life
Throughout a mother’s journey—from preconception, through pregnancy, to early childcare—Eurofins GENTIS is always ready to support with advanced genetic testing solutions, ensuring comprehensive and science-based care for both mother and baby.
In just one morning, mothers gain knowledge, connection, confidence, and love. That is the goal of the prenatal class and the values Eurofins GENTIS wishes to share.
Wishing all mothers a safe, healthy, and happiness-filled pregnancy.
[content_more] => [meta_title] => Eurofins GENTIS partners with Hanoi hospital of andrology and infertility to host the december prena [meta_description] => The journey of pregnancy is a sacred experience, one filled with unique emotions for every mother. It is the overwhelming joy of discovering the presence of a beloved baby, the day-by-day anticipation of feeling those first tiny movements, and at the same [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1392 [category_id] => 14 ) [2] => stdClass Object ( [id] => 1391 [id_crawler] => [category_product] => NULL [thumbnail] => 580472851_1241583017989313_4603897227992683883_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-12 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-12-12 14:43:52 [updated_time] => 2025-12-22 14:48:06 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-congratulates-the-25th-French–Vietnamese-congress-of-obstetrics-and-gynecology-2025-on-its-great-success [title] => Eurofins GENTIS congratulates the 25th French–Vietnamese congress of obstetrics and gynecology 2025 on its great success [description] => Over two days, November 9–10, 2025, at the National Convention Center, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 jointly organized by the National Hospital of Obstetrics and Gynecology (NHOG) and the French National College of Gynecologists and Obstetricians (CNGOF)—was held with remarkable success. The congress welcomed more than 1,500 delegates, including leading experts, physicians, scientists, and research institutions from Vietnam and abroad. This prestigious scientific event marked over 25 years of strong and enduring collaboration between Vietnam and France in obstetrics and gynecology, reproductive health, and maternal and child care. [content] =>This year’s congress was not only a large-scale academic forum, but also an opportunity for professionals to update the latest knowledge, share practical experience, and foster collaboration aimed at improving the quality of medical care in Vietnam.
Eurofins GENTIS is honored to accompany the congress as a sponsor
As a pioneer in medical genetic testing, Eurofins GENTIS was proud to accompany the 25th Vietnam–France Congress of Obstetrics and Gynecology as a sponsor. Participation in this important event provided a valuable opportunity for GENTIS to reaffirm its position while connecting with the professional community to disseminate modern scientific and technological values to physicians, researchers, and hospitals nationwide.
Amid the growing demand for genetic testing and reproductive support, Eurofins GENTIS is committed to delivering accurate, safe, and rapid testing services to customers and partners, leveraging advanced technologies from the Eurofins Group—one of the world’s leading laboratory networks.
Exhibition Booth – A Highlight of the Congress
At the congress, Eurofins GENTIS introduced a modern exhibition booth and in-depth consultation area, presenting comprehensive solutions in genetics and reproductive medicine. The most highly regarded services included:
- Non-Invasive Prenatal Testing (NIPT)
A solution that analyzes cell-free fetal DNA in maternal blood to enable early detection of chromosomal aneuploidies, ensuring absolute safety for both mother and baby. - Preimplantation Genetic Testing (PGT)
PGT techniques help select genetically healthy embryos prior to uterine transfer, improving IVF success rates and reducing the risk of inherited diseases. - Genetic Disease Detection and Carrier Screening, Pre-marital and Preconception Counseling
Designed for couples preparing for marriage or pregnancy, helping to minimize risks associated with recessive genetic disorders. - Andrology Testing and Other Specialized Tests
Including sperm DNA fragmentation analysis, semen quality assessment, and services supporting infertility and subfertility treatment.
The Eurofins GENTIS booth attracted a large number of congress participants. Many domestic and international experts engaged in direct professional discussions with the GENTIS specialist team. These exchanges opened up valuable collaboration opportunities, promoting broader clinical application of modern genetic technologies in Vietnam.
In addition to its professional exhibits, GENTIS also organized interactive minigames with attractive prizes, creating a lively and friendly atmosphere—an activity warmly welcomed by many delegates.
Supporting the Scientific Presentation by Associate Professor Dr. Trinh The Son
One of the most notable scientific sessions at the congress was the presentation by Associate Professor Dr. Trinh The Son, Director of the Military Institute of Clinical Embryology, entitled “Genetics in Assisted Reproduction: Advances and Future Directions.” Eurofins GENTIS was honored to provide state-of-the-art genetic testing information for this valuable scientific report.
In his presentation, Associate Professor Dr. Trinh The Son highlighted major advances in genetics applied to assisted reproduction, ranging from chromosomal analysis and gene sequencing technologies to optimize embryo selection strategies in IVF.
He particularly emphasized the practical value of advanced tests such as PGT-Next, PGT-Upgrade, WES (Whole Exome Sequencing), and WGS (Whole Genome Sequencing). These techniques are currently implemented by Eurofins GENTIS in accordance with international standards, supporting physicians and patients in achieving higher success rates in infertility treatment.
The presentation received strong attention from the professional community, offering fresh perspectives on trends in applying genetics to modern reproductive medicine.
The Mark of a Successful Congress
After two dynamic working days, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 left a lasting impression. Beyond its academic success with dozens of high-quality scientific presentations, the event demonstrated a strong spirit of international collaboration, promoting exchanges between Vietnamese and French experts toward a shared goal: improving the quality of reproductive healthcare for the community.
The success of the congress stands as clear evidence of the Vietnamese obstetrics and gynecology sector’s continuous efforts to access new knowledge, technologies, and advanced global treatment standards.
Eurofins GENTIS extends its warmest congratulations to the Organizing Committee, experts, speakers, and all delegates who contributed to a vibrant, professional, and meaningful congress. We believe that the values, knowledge, and directions shared at this year’s event will continue to drive the development of obstetrics and gynecology in Vietnam, enabling more families to access advanced, safe, and effective medical solutions.
In the time ahead, Eurofins GENTIS will continue to accompany physicians, hospitals, and assisted reproduction centers nationwide, delivering high-quality testing services that meet international standards—contributing to the enhancement of reproductive health for the Vietnamese community.
[content_more] => [meta_title] => Eurofins GENTIS congratulates the 25th French–Vietnamese congress of obstetrics and gynecology 2025 [meta_description] => Over two days, November 9–10, 2025, at the National Convention Center, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 jointly organized by the National Hospital of Obstetrics and Gynecology (NHOG) and the French National College of [meta_keyword] => GENTIS,Conference [thumbnail_alt] => [post_id] => 1391 [category_id] => 14 ) [3] => stdClass Object ( [id] => 1388 [id_crawler] => [category_product] => NULL [thumbnail] => 600x400-web-1.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-12-08 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-12-08 09:05:03 [updated_time] => 2025-12-10 15:48:02 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-participates-in-HASAM-2025-annual-scientific-conference-with-two-in-depth-reports-on-genetics [title] => Eurofins GENTIS participates in HASAM 2025 annual scientific conference with two in-depth reports on genetics [description] => The demand for reproductive healthcare is rising, and assisted reproductive technologies (ART) continue to advance rapidly. As a result, specialized scientific conferences play a crucial role in updating knowledge, strengthening professional networks, and improving treatment outcomes. The HASAM 2025 Annual Scientific Conference once again affirms its position as one of the most reputable professional events in Vietnam in the field of infertility and reproductive medicine. [content] =>Key highlights
With the theme “Updates on Scientific and Technical Advances to Improve Treatment Outcomes in Infertility”, the conference took place on December 14, 2025, at the National Convention Center (Hanoi), featuring 27 in-depth presentations and the participation of leading experts, doctors, researchers, and representatives from major IVF centers nationwide.
Eurofins GENTIS – a pioneering unit in genetic testing in Vietnam – was honored to accompany the event, aiming to contribute practical scientific value and bring more opportunities to couples hoping to have children.
HASAM 2025 – A prestigious scientific forum for Vietnam’s assisted reproduction field
Over the years, the Annual Scientific Conference of the Hanoi Assisted Reproduction Society (HASAM) has become a meeting place for the IVF community in Vietnam to exchange knowledge, share expertise, and update the latest scientific insights.
This year’s conference places strong emphasis on innovations in assisted reproduction, including:
-
Policies and development directions for assisted reproduction in Vietnam
-
Updates on ESHRE 2025 guidelines for ovarian stimulation
-
Advances in genetic screening, AI applications, and microfluidic technology
-
Optimization of treatment outcomes and individualized IVF protocols
-
Population aging and insights from reproductive medicine specialists
The presence of 27 specialized presentations painted a comprehensive picture of the latest scientific trends, contributing to the sustainable, internationally aligned development of ART in Vietnam.
Eurofins GENTIS proudly contributes two in-depth reports at HASAM 2025
As a member of Eurofins Scientific—a global leader in laboratory testing with more than 900 laboratories in 62 countries—Eurofins GENTIS consistently focuses on raising quality standards and developing advanced genetic applications for infertility treatment.
At HASAM 2025, Eurofins GENTIS presented two specialized reports, demonstrating its strong commitment to research and innovation:
-
Dr. Nguyenn Quang Vinh (Laboratory Director, Eurofins GENTIS): Comprehensive Quality Management of Genetic and Genomic Laboratories in Assisted Reproduction
-
Dr. Pham Dinh Minh (R&D Director, Eurofins GENTIS): Application of AI and Bioinformatics in Preimplantation Genetic Testing (PGT-AI)
Eurofins GENTIS booth – A space for knowledge exchange and genetic technology
Alongside its presentations, Eurofins GENTIS showcased an engaging exhibition booth that attracted widespread attention from experts and attendees. Visitors were introduced to a comprehensive ecosystem of genetic testing services in:
-
Assisted Reproduction: PGT-A/SR, PGT-M (100+ rare diseases), PGT-Upgrade, PGT-Next, Karyotype, …
-
Obstetrics: NIPT, double test, triple test, GEN9, preeclampsia screening,...
-
Andrology: Sperm DNA fragmentation, AZF testing, CFTR, …
-
Clinical Genetics: Genetic disease panels, comprehensive gene panels, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)
The booth also featured an exciting mini-game program with various gifts for delegates visiting the Eurofins GENTIS area. It served as a space for in-depth discussions between Eurofins GENTIS experts and doctors, embryologists, and IVF specialists from centers across the country.
Through this activity, Eurofins GENTIS aims to promote scientific value, share knowledge, and accompany the medical community in improving reproductive healthcare quality in Vietnam.
Commitment to enhancing Vietnamese health and well-being
With the mission “Improving the Intelligence and Physical Well-being of Vietnamese People”, Eurofins GENTIS continuously strives to apply modern technologies in genetic testing to meet the increasing needs of assisted reproduction, providing practical value that helps couples increase their chances of welcoming healthy babies.
Its participation in HASAM 2025 once again reaffirms Eurofins GENTIS's commitment to supporting the medical community, advancing research, and bringing cutting-edge technologies closer to Vietnamese people.
Eurofins GENTIS respectfully invites doctors, experts, and attendees to visit our booth at HASAM 2025 on Sunday, December 14, 2025, at the National Convention Center, Hanoi.
[content_more] => [meta_title] => Eurofins GENTIS participates in HASAM 2025 annual scientific conference with two in-depth reports on [meta_description] => The demand for reproductive healthcare is rising, and assisted reproductive technologies (ART) continue to advance rapidly. As a result, specialized scientific conferences play a crucial role in updating knowledge, strengthening professional networks, and [meta_keyword] => GENTIS,Hasam 2025 [thumbnail_alt] => [post_id] => 1388 [category_id] => 14 ) [4] => stdClass Object ( [id] => 1387 [id_crawler] => [category_product] => NULL [thumbnail] => ivf08616.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-12-12 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-12-04 08:33:25 [updated_time] => 2025-12-04 14:44:05 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => EUROFINS-GENTIS-conducts-technical-collaboration-at-Dong-Do-hospital-updates-on-ASEM-testing-in-assisted-reproduction [title] => EUROFINS GENTIS conducts technical collaboration at Dong Do hospital: updates on ASEM testing in assisted reproduction [description] => On November 28, the expert delegation from EUROFINS GENTIS, including Dr. Nguyen Quang Vinh (Director of the Genetic Counseling Center) and Dr. Pham Dinh Minh (Director of R&D), held a technical working session at Dong Do Hospital with the participation of the hospital’s reproductive medicine (IVF) team. This collaborative activity between EUROFINS GENTIS and Dong Do Hospital aimed to update the latest advances in genetic testing, thereby improving treatment outcomes for families struggling with infertility. The session not only facilitated academic exchange but also opened up new directions for long-term cooperation in the future. [content] =>The meeting was attended by Dr. Tang Duc Cuong (Specialist Level II) – Director of Dong Do IVF Center, MSc. Dr. Ngo Thi Diem – Head of the Obstetrics Department, along with physicians, nurses, and laboratory technicians from the hospital.
During the discussion, Dr. Nguyen Quang Vinh presented an overview of the cell-free DNA PGT (ASEM test), a non-invasive embryo culture medium-based genetic test currently attracting attention in the field of IVF. He explained that this technique analyzes cell-free DNA (cfDNA) released from embryonic cells through apoptosis or necrosis, originating from both the inner cell mass (ICM) and the trophectoderm. However, to ensure accuracy, it is crucial to completely eliminate maternal granulosa or cumulus cells, as contamination with exogenous DNA can significantly affect the results.
Dr. Vinh also addressed several studies comparing the concordance between cfDNA in the culture medium and traditional biopsy samples such as TE, ICM, or cord blood, providing a comprehensive view of the test’s clinical potential. He emphasized that laboratory procedures in the IVF unit play a decisive role in sample quality—from thoroughly removing surrounding cells after fertilization, changing culture medium on Day 3, washing embryos carefully on Day 4, to culturing embryos in a 20 µl drop from the afternoon of Day 4 to Day 5 for at least 22 hours to obtain sufficient DNA. When the embryo reaches Day 5/Day 6, the technician collapses the embryo and collects the entire medium into a PCR tube with a preservation buffer, ensuring tip changes between samples and storing at -20°C to -80°C before analysis.
The ASEM test can detect aneuploidies of 22 autosomes, large structural abnormalities greater than 40Mb, and can report mosaicism at levels of 50% or higher. Results are available within approximately 7 days. Based on analytical data, experts provided clinical suggestions such as considering the transfer of 46XX embryos, with 46XY embryos being more strongly recommended, while embryos carrying abnormalities such as -1q or -15 deletions are generally not advised for transfer. Dr. Vinh concluded by stressing that ASEM technology only delivers real value when embryo culture, washing, and medium collection processes in the IVF laboratory are meticulously executed, as precision in every step determines the reliability and clinical relevance of the test results.
The session provided in-depth knowledge and important updates, contributing to Dong Do Hospital’s application of advanced genetic technologies to improve the effectiveness of assisted reproductive treatments.
Beyond theoretical presentation, Dr. Nguyen Quang Vinh also addressed clinicians’ questions regarding real clinical cases. These detailed analyses helped the Dong Do medical team better understand the coordination process between the IVF laboratory, IVF center, and testing unit to optimize patient outcomes.
Continuing the session, Dr. Vinh emphasized EUROFINS GENTIS’s development direction in implementing new technologies, expanding collaboration with IVF centers, and enhancing testing quality according to international standards. Dong Do Hospital highly appreciated the expert team’s updated insights and reaffirmed its readiness to collaborate in improving assisted reproductive care.
Concluding the exchange, Dr. Tang Đuc Cuong expressed his gratitude to the EUROFINS GENTIS delegation. He highlighted that the updated knowledge on ASEM testing not only helps clinicians better understand the potential of modern genetic techniques but also opens new approaches for optimizing embryo selection in difficult IVF cases. He affirmed that Dong Do Hospital is committed to closely cooperating with EUROFINS GENTIS to standardize procedures, enhance sample quality, and progress toward adopting ASEM as an important clinical support tool in the near future. According to Dr. Cương, this partnership will bring practical benefits to patients, especially infertile couples hoping for a chance to become parents.
The session concluded in an open and collaborative atmosphere. The event reaffirmed EUROFINS GENTIS’s commitment to providing precise, modern, and effective testing solutions, contributing to increasing the chances of parenthood for thousands of Vietnamese families.
From fundamental techniques such as in vitro fertilization, medicine has continuously achieved remarkable progress. One of the most significant milestones is the application of genetics in assisted reproduction—allowing doctors not only to create embryos but also to select the healthiest ones, thereby increasing the chances of success.
According to Assoc. Prof. Dr. Trinh The Son – Director of the Military Clinical Embryology Institute, Vietnam Military Medical Academy – genetics now plays a pivotal role in the field of assisted reproduction. Through genetic and chromosomal analyses, doctors can identify the root causes of infertility at the deepest biological levels, detecting chromosomal abnormalities such as Klinefelter syndrome, Turner syndrome, or AZF microdeletions in men, as well as gene mutations that may lead to vas deferens obstruction or premature ovarian failure. More importantly, genetic information enables personalized treatment regimens tailored to each patient’s genetic characteristics.
One of the most prominent achievements in this field is preimplantation genetic testing (PGT). This technique allows doctors to select embryos with normal chromosomal makeup and eliminate those carrying abnormalities that may lead to miscarriage or genetic disorders. PGT includes several types such as PGT-A, PGT-M, and PGT-SR. PGT-A helps detect abnormalities in chromosome numbers, such as Down syndrome; PGT-M is used for couples carrying genetic diseases like Thalassemia or cystic fibrosis to ensure only embryos without the disease-causing gene are transferred; while PGT-SR helps detect structural chromosomal abnormalities such as translocations or inversions, proving particularly valuable in cases of recurrent miscarriage or unexplained infertility.
Beyond these, scientists are researching and applying non-invasive screening methods, notably niPGT – a technique analyzing cell-free DNA in embryo culture media, eliminating the need for embryo biopsy and improving embryo safety during development.
In addition, the emergence of advanced tests such as PGT NEXT, PGT UPGRADE, WES, and WGS is significantly improving success rates in assisted reproduction. PGT NEXT enables comprehensive chromosomal assessment of embryos, detecting aneuploidy, mono- and polyploidy, as well as structural abnormalities, while using SNP analysis to prevent sample mix-ups and accurately identify healthy diploid embryos. PGT UPGRADE goes a step further by detecting embryos carrying balanced translocations inherited from parents—a common cause of recurrent miscarriage—allowing doctors to select embryos without such abnormalities and improving the chances of a healthy pregnancy for couples with chromosomal translocations.
Meanwhile, WES (whole exome sequencing) and WGS (whole genome sequencing) open the door to identifying rare, complex, or previously unknown mutations related to infertility. WES examines more than 22,000 coding genes—where most disease-causing variants are concentrated—while WGS provides the most comprehensive genomic overview, helping doctors uncover deep-seated causes in difficult cases, thereby personalizing treatment plans and optimizing patient success rates.
Artificial intelligence and big data analytics are also becoming powerful tools for selecting embryos with the highest developmental potential. AI systems can analyze thousands of data points on embryo morphology and development speed to suggest the healthiest embryo, significantly increasing success rates for infertile couples.
Genetics not only enhances the effectiveness of infertility treatment but also aims toward selecting healthy embryos, ensuring precise treatment, and preventing genetic diseases. Assoc. Prof. Dr. Trinh The Son emphasizes that it is essential to approach these technologies with humanity and responsibility so that science truly serves human happiness.
On the journey toward parenthood, each advancement in genetic medicine is a beacon of hope—illuminating the dreams of millions of infertile families and bringing them closer to the “miracle of life.”
[content_more] => [meta_title] => Genetics in assisted reproduction – breakthroughs bringing new hope to infertile couples [meta_description] => Over the years, infertility has become one of the major concerns of modern medicine. Statistics show that as many as 12.6% of couples worldwide face difficulties in conceiving. [meta_keyword] => GENTIS,PGT,WES,WGS [thumbnail_alt] => [post_id] => 1380 [category_id] => 14 ) [6] => stdClass Object ( [id] => 1379 [id_crawler] => [category_product] => NULL [thumbnail] => hoi-nghi-khoa-hoc-hosrem-lan-thu-20.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-17 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-17 14:25:06 [updated_time] => 2025-11-21 10:09:07 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-accompanies-the-20th-annual-HOSREM-scientific-conference [title] => Eurofins GENTIS accompanies the 20th annual HOSREM scientific conference [description] => On November 23, 2025, the 20th Annual HOSREM Scientific Conference will officially take place at the Equatorial Hotel in Ho Chi Minh City, marking an important milestone for one of the most prestigious scientific forums in the fields of obstetrics–gynecology and reproductive health in Vietnam. This year, Eurofins GENTIS is honored to join the conference as the main sponsor, offering a wide range of professional activities and meaningful interactions for attending delegates. [content] =>HOSREM – 20 Years of Knowledge Building and Expert Connection
The HOSREM Annual Scientific Conference is a reputable forum in obstetrics–gynecology and reproductive health, where the latest knowledge and advances are shared by leading experts. Over the past 20 years, HOSREM has grown into a major scientific event, gathering numerous delegates from hospitals and medical centers across the country.
Beyond being a venue for updating specialized knowledge, HOSREM serves as a bridge connecting scientific research, clinical experience, and practical applications in reproductive healthcare. Throughout its 20 editions, HOSREM has consistently remained a trusted platform for academic exchange and for sharing the latest medical advancements. It also promotes collaboration among hospitals, medical centers, and research institutes both domestically and internationally. In addition, HOSREM inspires innovation and encourages the integration of technology into reproductive healthcare in Vietnam.
This year's conference continues to bring together leading experts from major hospitals, reproductive centers, laboratories, and healthcare organizations nationwide, offering a comprehensive and in-depth picture of the current landscape in obstetrics and gynecology.
2025 Conference Themes: Addressing Key Issues in Clinical Practice
The 20th HOSREM Conference will focus on practical and highly relevant topics in obstetrics, gynecology, and assisted reproduction. This year’s program highlights common and critical issues in clinical practice, featuring engaging presentations by seasoned experts and physicians, promising valuable updates and insights for all attendees.
A major highlight of this year’s event is the participation of top Vietnamese specialists in IVF, fetal medicine, medical genetics, and reproductive healthcare. They will present up-to-date research findings, unique clinical cases, and emerging trends that help improve treatment outcomes.
In addition to scientific presentations, open discussion sessions will offer delegates the opportunity to exchange experiences, share clinical challenges, and explore feasible solutions for patients in today’s context.
Eurofins GENTIS – Partnering with HOSREM for a future of comprehensive reproductive health
With the mission “Enhancing the Physical and Intellectual Well-being of Vietnamese People,” Eurofins GENTIS joins HOSREM 2025 as a main sponsor, bringing advanced genetic solutions that support obstetrics and assisted reproduction.
Over the years, Eurofins GENTIS has continuously improved testing quality by adopting cutting-edge technologies from Eurofins Scientific—one of the world’s largest laboratory groups. GENTIS’s specialized genetic tests play a significant role in:
- Optimizing IVF cycles through embryo genetic assessments (PGT-A/PGT-SR, PGT-M for 100+ rare diseases, PGT-Upgrade, PGT-Next).
- Preconception carrier screening for couples to reduce the risk of passing on genetic disorders.
- Non-invasive prenatal testing (NIPT) for early detection of chromosomal abnormalities in the first trimester.
- Testing to evaluate treatment responsiveness in infertility, helping physicians develop tailored protocols.
Eurofins GENTIS firmly believes that integrating genetic testing into clinical practice not only improves treatment efficacy but also gives families the chance to welcome healthy babies while reducing risks and healthcare burdens.
Eurofins GENTIS Booth – A Highlight of the Conference
At this year’s conference, the Eurofins GENTIS booth is designed to provide a friendly and modern space where delegates can:
- Receive direct consultation from experts on genetic testing for obstetrics and assisted reproduction.
- Access the latest updates on the company’s genetic testing solutions.
- Participate in a mini-game program for visitors—an engaging activity aimed at creating a lively atmosphere and expressing our appreciation to the physicians and experts who have supported GENTIS over the years.
We believe that the development of obstetrics, gynecology, and assisted reproduction cannot be separated from the advancement of genetic testing technologies. Our continued partnership with HOSREM reflects GENTIS’s commitment to contributing to shared goals:
- Improving treatment quality for infertility patients.
- Helping reduce birth defects through genetic screening and diagnosis.
- Supporting physicians in staying updated on new research and technologies.
As the demand for reproductive healthcare grows, the integration of genomics into clinical practice becomes essential to ensure optimal treatment outcomes and improve population health.
The 20th Annual HOSREM Scientific Conference promises to be a knowledge-rich, inspiring event that fosters meaningful collaborations among medical institutions, hospitals, reproductive centers, and laboratories nationwide.
Eurofins GENTIS warmly invites all delegates to visit our booth for professional exchange, information sharing, and hands-on experience with the most advanced genetic solutions available today.
We look forward to welcoming you at HOSREM 2025—where knowledge converges, connections flourish, and innovation begins!
[content_more] => [meta_title] => Eurofins GENTIS accompanies the 20th annual HOSREM scientific conference [meta_description] => On November 23, 2025, the 20th Annual HOSREM Scientific Conference will officially take place at the Equatorial Hotel in Ho Chi Minh City, marking an important milestone for one of the most prestigious scientific forums in the fields of obstetrics–gynecol [meta_keyword] => GENTIS,HOSREM [thumbnail_alt] => [post_id] => 1379 [category_id] => 14 ) [7] => stdClass Object ( [id] => 1378 [id_crawler] => [category_product] => NULL [thumbnail] => 48be86a032fdbea3e7ec.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-03 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-03 10:24:41 [updated_time] => 2025-11-21 10:13:42 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-accompanies-the-25th-Vietnam-France-obstetrics-and-gynecology-conference-2025 [title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. This prestigious annual scientific event in obstetrics and gynecology is hosted by the National Hospital of Obstetrics and Gynecology (NHOG) in collaboration with the French National College of Gynecologists and Obstetricians (CNGOF). [content] =>This year’s conference marks 25 years of effective cooperation between the two nations in training, research, and the transfer of medical advances—aiming to improve reproductive healthcare quality and contribute to the protection and development of the Vietnamese population.
With 1,500 delegates attending onsite and another 1,000 participating online, the conference gathers leading scientists, physicians, and specialists from Vietnam, France, and many other countries. It serves as an important academic platform for experts to exchange and update the latest knowledge in obstetrics, gynecology, assisted reproduction, and medical genetics.
Eurofins GENTIS – Sponsoring Partner of the 2025 Vietnam–France Obstetrics and Gynecology Conference
With the mission “Enhancing the Intellectual and Physical Well-being of Vietnamese People,” Eurofins GENTIS is honored to accompany the 25th Vietnam–France Obstetrics and Gynecology Conference as a sponsor. Our presence at the event reflects not only our spirit of cooperation and commitment to the medical community but also our dedication to promoting the scientific value and practical application of genetic testing in reproductive healthcare.
Over the past 15 years, Eurofins GENTIS has become a pioneer in genetic testing in Vietnam, operating a network of laboratories accredited by CAP and ISO 15189:2022, and supported by leading domestic and international scientific advisors. GENTIS provides genetic testing services that serve individuals and families while also supporting obstetricians and gynecologists in diagnosis, pregnancy monitoring, and the management of reproductive health issues.
GENTIS Booth – A Genetic Technology Highlight at the Conference
At this year’s Vietnam–France Obstetrics and Gynecology Conference, Eurofins GENTIS introduces an exhibition and consultation booth where delegates can explore comprehensive genetic testing solutions.
Featured services include:
- NIPT (Non-invasive Prenatal Testing) for early detection of chromosomal abnormalities in fetuses from week 9.
- Preimplantation Genetic Testing (PGT) to support IVF centers in selecting healthy embryos, increasing pregnancy rates, and improving birth outcomes.
- Genetic disease carrier testing, enabling the detection of recessive gene carriers and providing premarital and preconception counseling.
- Andrology testing to support diagnosis and treatment in male fertility.
In addition to showcasing technologies and services, the GENTIS team will be present to answer questions and offer expert consultation to physicians, researchers, and attendees. The Eurofins GENTIS booth is designed with a modern, open layout, creating a friendly and effective space for discussion.
Exciting Minigame – Connect with GENTIS and Receive Instant Gifts
To bring a more engaging and interactive experience to delegates, Eurofins GENTIS is hosting an interactive minigame at our booth throughout the conference.
With simple participation steps, visitors can join quick interactive activities or answer questions related to genetics and reproductive health to receive meaningful and surprising gifts from GENTIS.
Beyond entertainment, the minigame serves as a bridge to help physicians, scientists, and guests better understand the vital role of genetics in modern medicine—from prenatal screening and assisted reproduction to community genetic counseling.
Through these approachable activities, GENTIS aims to spread the message:
“Genetics is not distant—it is a companion in every family’s reproductive healthcare journey.”
Supporting the Advancement of Obstetrics and Gynecology in Vietnam
In recent years, cooperation between Vietnam and France in obstetrics and gynecology has achieved remarkable progress. The conference is not only a platform for academic exchange but also a venue for connecting institutions, hospitals, enterprises, and research centers to promote the application of advanced science in clinical practice.
GENTIS is proud to be part of this journey. By continuously investing in technology, enhancing professional quality, and expanding international cooperation, we aim to bring advanced genetic testing closer to Vietnamese people and support healthcare professionals in diagnosing, treating, and preventing genetic diseases.
GENTIS – A Trusted Partner in Medical Genetics
With core values of “Integrity, Innovation, Dedication, Respect, and Continuous Learning,” Eurofins GENTIS has become a trusted partner of hundreds of hospitals, IVF centers, and healthcare institutions nationwide. Our products, services, and research initiatives are designed to enhance population health, support safe and effective reproduction, and align with Vietnam’s comprehensive healthcare orientation.
Our sponsorship of the 2025 Vietnam–France Obstetrics and Gynecology Conference demonstrates our commitment to sharing knowledge, creating value, and contributing to the modernization of Vietnamese medicine toward international standards.
The 25th Vietnam–France Obstetrics and Gynecology Conference promises to be one of the most significant scientific events of 2025, opening new directions in research, collaboration, and application in reproductive healthcare.
Eurofins GENTIS warmly invites physicians, specialists, and delegates to visit the GENTIS booth to explore advanced genetic solutions, update new trends, and participate in our exciting minigame for a chance to receive special gifts.
[content_more] => [meta_title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [meta_description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1378 [category_id] => 14 ) )
Preimplantation genetic testing: A key to improving IVF success and protecting future generations
Eurofins GENTIS partners with Hanoi hospital of andrology and infertility to host the december prenatal class
Eurofins GENTIS congratulates the 25th French–Vietnamese congress of obstetrics and gynecology 2025 on its great success
Eurofins GENTIS participates in HASAM 2025 annual scientific conference with two in-depth reports on genetics
EUROFINS GENTIS conducts technical collaboration at Dong Do hospital: updates on ASEM testing in assisted reproduction
Genetics in assisted reproduction – breakthroughs bringing new hope to infertile couples
Eurofins GENTIS accompanies the 20th annual HOSREM scientific conference
Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025)
Please fill in the information below to receive our supports and consultations!
Please fill in the information below to receive our supports and consultations!
